The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 48%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (6 analysts) rates it hold, with a mean price target of $12.
Adamas Trust, Inc.
ADAM · Nasdaq · USD · Market cap $837M · 221 employees
Adamas Trust, Inc.
FAIL · Does not pass the screenAt the last full screen
2026-06-14
Screened 2026-06-14 · the tape above runs as of 23:00 UTC · 20 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
What this means: price 9.31 against the desk's fair-value range, base estimate 12.03, over the last year.
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against today's price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markdown label.
Adamas Trust, Inc. holds its Markdown at $9.31. The statistical read favours the sellers, held for 7 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 7 days |
| Price at the screen | $9.31 |
| Valuation | 7.96 trailing · 8.71 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 1.25 |
Five Screens, Shown in Full
Does not pass. Prohibited keyword in sector/industry: mortgage
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Prohibited keyword in sector/industry: mortgage | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-06-14 screen. The gold marker is the market price at the same screen. A 29.2% margin of safety to the base estimate.
Third-party analyst targets: 6 covering, consensus None. The average target sits +3% from the screen price.
Reading the gap · Our model sees value the Street hasn't fully caught up to yet.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-06-14 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words| Forward P/E | 8.7xfairly priced for its growth rate |
| Trailing P/E | 8.0xvery cheap relative to earnings |
| EPS, trailing | 1.17 |
| EPS, forward | 1.07 |
| Revenue growth | +10.7%steady growth |
| Profit margin | 48.1%highly profitable on every dollar of sales |
| Return on equity | 13.0%a solid return on shareholder capital |
| Dividend yield | 1,031.00% |
| Debt to equity | 7.65heavy leverage: higher risk if revenue softens |
| Current ratio | 0.82below 1: short-term bills exceed liquid assets |
| Beta | 1.25moves a little more than the market |
| Short interest, float | 0.03% |
| 52-week range | 6.16 - 9.48 |
| Market cap | $837M |
| Employees | 221 |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeADAM trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 48%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (6 analysts) rates it hold, with a mean price target of $12.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 48%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (6 analysts) rates it hold, with a mean price target of $12.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 48%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (6 analysts) rates it hold, with a mean price target of $12.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 48%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (6 analysts) rates it hold, with a mean price target of $12.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $8.66 | +4.7% | · | $1,047 | +4.7% |
| 2 months | $7.59 | +19.5% | · | $1,195 | +19.5% |
| 3 months | $7.66 | +18.4% | $0.23 | $1,214 | +21.4% |
| 6 months | $6.68 | +35.7% | $0.46 | $1,426 | +42.6% |
| 1 year | $6.14 | +47.8% | $0.89 | $1,623 | +62.3% |
| 2 years | $4.52 | +100.5% | $1.69 | $2,379 | +137.9% |
| 3 years | $6.88 | +31.8% | $2.69 | $1,709 | +70.9% |
| 5 years | $10.17 | -10.8% | $5.89 | $1,471 | +47.1% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever ADAM does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.